Literature DB >> 15568776

Cassane- and norcassane-type diterpenes of Caesalpinia crista from Myanmar.

Surya K Kalauni1, Suresh Awale, Yasuhiro Tezuka, Arjun H Banskota, Thein Zaw Linn, Shigetoshi Kadota.   

Abstract

From the CH(2)Cl(2) extract of seed kernels of Caesalpinia crista from Myanmar, five new cassane-type diterpenes, caesalpinins MA-ME (1-5), and three new norcassane-type diterpenes, norcaesalpinins MA-MC (6-8), have been isolated, together with 12 known cassane-type diterpenes, 14(17)-dehydrocaesalmin F, caesaldekarin e, caesalmin B, caesalmin C, caesalmin E, 2-acetoxy-3-deacetoxycaesaldekarin e, 2-acetoxycaesaldekarin e, caesalpinin C, 7-acetoxybonducellpin C, caesalpinin E, norcaesalpinin B, and 6-acetoxy-3-deacetoxycaesaldekarin e. The structures of the isolated compounds were elucidated by analysis of their spectroscopic data.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568776     DOI: 10.1021/np049742m

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Bioactive Compounds from Medicinal Plants in Myanmar.

Authors:  Nwet Nwet Win; Hiroyuki Morita
Journal:  Prog Chem Org Nat Prod       Date:  2021

2.  Antiproliferative cassane diterpenoids of Cordyla madagascariensis ssp. madagascariensis from the Madagascar rainforest.

Authors:  Yanpeng Hou; Shugeng Cao; Peggy Brodie; James S Miller; Chris Birkinshaw; Fidisoa Ratovoson; Roland Rakotondrajaona; Rabodo Andriantsiferana; Vincent E Rasamison; David G I Kingston
Journal:  J Nat Prod       Date:  2007-12-29       Impact factor: 4.050

3.  Acid-catalyzed transformation of cassane diterpenoids from Caesalpinia bonduc to aromatic derivatives.

Authors:  Ting Liu; Zunxi Ning; Yan Yin; Shizhou Qi; Huiyuan Gao
Journal:  RSC Adv       Date:  2021-06-22       Impact factor: 4.036

4.  Hepatoprotective Potential of Caesalpinia crista against Iron-Overload-Induced Liver Toxicity in Mice.

Authors:  Rhitajit Sarkar; Bibhabasu Hazra; Nripendranath Mandal
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-17       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.